![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MabCure Inc (CE) | USOTC:MBCI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
UNITED STATES SECURITIES
AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 9, 2011
MABCURE INC.
(Exact
name of registrant as specified in its charter)
Nevada
(State or other jurisdiction of
incorporation)
333-141131
(Commission File Number)
20-4907813
(IRS Employer
Identification No.)
760 Parkside Avenue #208
Brooklyn, NY 11226
(Address of principal executive offices and Zip Code)
(914) 595-6342
(Registrant's
telephone number, including area code)
De Schiervellaan 3/B1
3500 Hasselt, Belgium
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 4.01 | Changes in Registrants Certifying Accountant. |
Explanatory Note
MabCure Inc., a Nevada corporation, (the Company) filed a Current Report on Form 8-K with the Securities and Exchange Commission (the SEC) on March 14, 2011 to report a change in the Companys certifying accountant (Original Filing). The text below and Exhibit 16.1 attached hereto shall amend and supplement the original filing made on March 14, 2011. This Amendment No. 1 to Form 8-K (Amendment) supplements our Original Filing. This Amendment is filed to incorporate the letter from Etania Audit Group, P.C., formerly Davis Accounting Group, P.C., provided pursuant to the requirements of Item 4.01.
Except as described above, no other changes have been made to the Original Filing and this Amendment does not modify or update any other information in the Original Filing. Information not affected by the changes described above is unchanged and reflects the disclosures made at the time of the Original Filing. Accordingly, this Form 8-K/A should be read in conjunction with the Companys filings made with the Securities and Exchange Commission subsequent to the date of the Original Filing.
Item 9.01 | Financial Statements and Exhibits. |
Exhibit No. | Description of Exhibit. |
16.1 | Letter from Etania Audit Group, P.C. to the United States Securities and Exchange Commission dated April 6, 2011. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MABCURE INC.
(Registrant)
By:
/s/ Dr. Amnon Gonenne
Dr. Amnon Gonenne
President and Chief Executive Officer
Date: April 7, 2011
1 Year MabCure (CE) Chart |
1 Month MabCure (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions